Sabiia Seb
PortuguêsEspañolEnglish
Embrapa
        Busca avançada

Botão Atualizar


Botão Atualizar

Ordenar por: 

RelevânciaAutorTítuloAnoImprime registros no formato resumido
Registros recuperados: 3
Primeira ... 1 ... Última
Imagem não selecionada

Imprime registro no formato completo
Drug repositioning, a new alternative in infectious diseases BJID
Serafin,Marissa Bolson; Hörner,Rosmari.
Tipo: Info:eu-repo/semantics/other
Ano: 2018 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000300252
Imagem não selecionada

Imprime registro no formato completo
Synergistic antibacterial effect of statins with the complex {[1-(4-bromophenyl)-3-phenyltriazene N 3 -oxide-κ 2 N 1 ,O 4 ](dimethylbenzylamine-κ 2 C 1 ,N 4 )palladium(II)} BJPS
Rampelotto,Roberta Filipini; Lorenzoni,Vinicius Victor; Silva,Danielly da Costa; Moraes,Guilherme A. de; Serafin,Marissa Bolson; Tizotti,Maísa Kräulish; Coelho,Silvana; Zambiazi,Priscilla; Hörner,Manfredo; Hörner,Rosmari.
Abstract The treatment of infections caused by resistant microorganisms represents a big challenge in healthcare due to limited treatment options. For this reason, the discovery of new active substances which are able to perform innovative and selective actions is of great impact nowadays. Statins and triazenes (TZC) have consolidated as a promising class of compounds, characterized by the expressive biological activity, especially antimicrobial activities. The aim of this study was to assess the in vitro synergistic antibacterial effect of the association of statins and a new TZC complex {[1-(4-bromophenyl)-3-phenyltriazene N 3-oxide-κ 2 N 1,O 4](dimethylbenzylamine-κ 2 C 1,N 4)palladium(II)} (Pd(DMBA)LBr) against American Type Culture Collection (ATCC)...
Tipo: Info:eu-repo/semantics/article Palavras-chave: Statins/antimicrobial activity; Triazenide; Atorvastatin; Simvastatin..
Ano: 2018 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000200614
Imagem não selecionada

Imprime registro no formato completo
Synergistic effect of sertraline and disulfiram against multidrug resistant bacteria as a new alternative to drug repositioning BJPS
Serafin,Marissa Bolson; Bottega,Angelita; Foletto,Vitória Segabinazzi; Rosa,Taciéli Fagundes da; Rampelotto,Roberta Filipini; Carvalho,Fernanda Aguirre; Hörner,Rosmari.
The repositioning of approved drugs is atopic of interest for the academy and the pharmaceutical industry. The synergistic combination of these drugs can be successful in the treatment of infections caused by resistant bacteria. This study aimed to assess the in vitro synergistic antibacterial activity of sertraline and disulfiram and their interaction with ciprofloxacin and sulfamethoxazole/trimethoprim. We determined the minimum inhibitory concentration, the minimum bactericidal concentration and the fractional inhibitory concentration index. Eighteen bacterial strains were used, being nine American Type Culture Collection reference strains and nine multidrug resistant clinical isolates. Synergy was detected between sertraline and disulfiram against a...
Tipo: Info:eu-repo/semantics/article Palavras-chave: Sertraline; Disulfiram.Antimicrobial activity; Drug synergism; Drug repositioning.
Ano: 2020 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502020000100548
Registros recuperados: 3
Primeira ... 1 ... Última
 

Empresa Brasileira de Pesquisa Agropecuária - Embrapa
Todos os direitos reservados, conforme Lei n° 9.610
Política de Privacidade
Área restrita

Embrapa
Parque Estação Biológica - PqEB s/n°
Brasília, DF - Brasil - CEP 70770-901
Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco

Valid HTML 4.01 Transitional